Mesothelioma is a malignant lung cancer that is commonly associated with previous asbestos exposure. Often it is not diagnosed until too late to treat in a patient. Calretinin has recently been in the spotlight as a potential biomarker for early detection of mesothelioma.
Two recent studies used Eagle Bioscience’s Calretinin ELISA Assay kit analyzing the accuracy of using Calretinin as a prediagnostic technique for mesothelioma:
- Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population.
Aguilar-Madrid, Guadalupe, et al. “Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population .” International Journal of Medical Sciences, vol. 15, no. 9, 2018, pp. 883–891.
- Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin – a case-control comparison nested into a prospective cohort of asbestos-exposed workers.
Johnen, G., Burek, K., Raiko, I., Wichert, K., Pesch, B., Weber, D. G., . . . Brüning, T. (2018). Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin – a case-control comparison nested into a prospective cohort of asbestos-exposed workers. Scientific Reports,8(1).
Learn more about our Calretinin ELISA Assay kit here.